ResearcherAll India Institute of Medical SciencesActive in the last 2 years
Kiran Kumar Tejavath
Matched on ORCID iD 0000-0001-7876-421X; OpenAlex author ID A5050093634. Sources: OpenAlex.
Their work
- Papers
- 5 (first author 1, last author 4)
- Trials
- 0
- Grants
- 0
- Labs led
- 1
- Collaborators
- 3
2021: 1 paper · 2022: none · 2023: 1 paper · 2024: none · 2025: 1 paper · 2026: 2 papers
Papers 5
- Understanding cytotoxicity induction by plumbagin in pancreatic ductal adenocarcinoma using network pharmacology, bioinformatic and in-vitro study. Last author DOI 10.1007/s10616-026-00912-0↗
- Gossypin suppresses mutant KRAS G12D driven oncogenic and adipogenic activity via NF-κB signaling in pancreatic cancer. First author DOI 10.1016/j.bbalip.2026.159779↗
- Caffeic acid, a dietary polyphenol, pre-sensitizes pancreatic ductal adenocarcinoma to chemotherapeutic drug. Last author DOI 10.1080/07391102.2024.2318481↗
- Pharmacoinformatic screening of phytoconstituent and evaluation of its anti-PDAC effect using in vitro studies. Last author DOI 10.1080/07391102.2022.2155701↗
- Unfolding antifungals: as a new foe to pancreatic ductal adenocarcinoma-a mini-review. Last author DOI 10.1007/s11033-021-06318-9↗
Closest collaborators
The 3 strongest of 3 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- Shruti Gupta · 4 shared papers, 2021–2026 · strength 1.36
- Paper Understanding cytotoxicity induction by plumbagin in pancreatic ductal adenocarcinoma using network pharmacology, bioin… DOI 10.1007/s10616-026-00912-0↗
- Paper Caffeic acid, a dietary polyphenol, pre-sensitizes pancreatic ductal adenocarcinoma to chemotherapeutic drug. DOI 10.1080/07391102.2024.2318481↗
- Paper Pharmacoinformatic screening of phytoconstituent and evaluation of its anti-PDAC effect using in vitro studies. DOI 10.1080/07391102.2022.2155701↗
- Jyoti Poswal · 1 shared paper, 2026 · strength 0.33
- Chandi Charan Mandal · 1 shared paper, 2026 · strength 0.33
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.